These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20388850)

  • 1. Differential functions of growth factor receptor-bound protein 7 (GRB7) and its variant GRB7v in ovarian carcinogenesis.
    Wang Y; Chan DW; Liu VW; Chiu P; Ngan HY
    Clin Cancer Res; 2010 May; 16(9):2529-39. PubMed ID: 20388850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation-associated silencing of
    Chen K; Liu MX; Mak CS; Yung MM; Leung TH; Xu D; Ngu SF; Chan KK; Yang H; Ngan HY; Chan DW
    Theranostics; 2018; 8(2):423-436. PubMed ID: 29290818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel variant of human Grb7 is associated with invasive esophageal carcinoma.
    Tanaka S; Mori M; Akiyoshi T; Tanaka Y; Mafune K; Wands JR; Sugimachi K
    J Clin Invest; 1998 Aug; 102(4):821-7. PubMed ID: 9710451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells.
    Lok GT; Chan DW; Liu VW; Hui WW; Leung TH; Yao KM; Ngan HY
    PLoS One; 2011; 6(8):e23790. PubMed ID: 21858223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression.
    Nencioni A; Cea M; Garuti A; Passalacqua M; Raffaghello L; Soncini D; Moran E; Zoppoli G; Pistoia V; Patrone F; Ballestrero A
    PLoS One; 2010 Feb; 5(2):e9024. PubMed ID: 20126311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells.
    Chan DW; Hui WW; Cai PC; Liu MX; Yung MM; Mak CS; Leung TH; Chan KK; Ngan HY
    PLoS One; 2012; 7(12):e52578. PubMed ID: 23285101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of growth factor receptor bound protein 7 suppresses angiogenesis by inhibiting the secretion of vascular endothelial growth factor A in ovarian cancer cells.
    Xu Q; Liu Z; Zhu ZQ; Fan Y; Chen R; Xie XH; Cheng M
    Bioengineered; 2021 Dec; 12(2):12179-12190. PubMed ID: 34783299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells.
    Gery S; Xie D; Yin D; Gabra H; Miller C; Wang H; Scott D; Yi WS; Popoviciu ML; Said JW; Koeffler HP
    Clin Cancer Res; 2005 Oct; 11(20):7243-54. PubMed ID: 16243794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.
    Tanaka S; Pero SC; Taguchi K; Shimada M; Mori M; Krag DN; Arii S
    J Natl Cancer Inst; 2006 Apr; 98(7):491-8. PubMed ID: 16595785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor receptor bound protein-7 regulates proliferation, cell cycle, and mitochondrial apoptosis of thyroid cancer cells via MAPK/ERK signaling.
    Tang H; Yang P; Yang X; Peng S; Hu X; Bao G
    Mol Cell Biochem; 2020 Sep; 472(1-2):209-218. PubMed ID: 32577949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCF12-regulated GRB7 facilitates the HER2+ breast cancer progression by activating Notch1 signaling pathway.
    Wang G; Wu Y; Su Y; Qu N; Chen B; Zhou D; Yuan L; Yin M; Liu M; Zhou W
    J Transl Med; 2024 Aug; 22(1):745. PubMed ID: 39113057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphorylation of growth factor receptor-bound protein-7 by focal adhesion kinase in the regulation of cell migration, proliferation, and tumorigenesis.
    Chu PY; Huang LY; Hsu CH; Liang CC; Guan JL; Hung TH; Shen TL
    J Biol Chem; 2009 Jul; 284(30):20215-26. PubMed ID: 19473962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grb7 gene amplification and protein expression by FISH and IHC in ovarian cancer.
    Zeng M; Yang Z; Hu X; Liu Y; Yang X; Ran H; Li Y; Li X; Yu Q
    Int J Clin Exp Pathol; 2015; 8(9):11296-304. PubMed ID: 26617853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Cyclic Peptide Inhibitors of the Grb7 Breast Cancer Target: Small Change in Cargo Results in Large Change in Cellular Activity.
    Sang J; Kulkarni K; Watson GM; Ma X; Craik DJ; Henriques ST; Poth AG; Benfield AH; Wilce JA
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31627265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20.
    He X; Ee PL; Coon JS; Beck WT
    Clin Cancer Res; 2004 Jul; 10(14):4652-60. PubMed ID: 15269137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated GRB7 promotes proliferation and tumorigenesis of Bladder Cancer via Phospho-AKT Pathway.
    Zheng Y; Pei Y; Yang L; Zeng Z; Wang J; Xie G; Wang L; Yuan J
    Int J Biol Sci; 2020; 16(16):3221-3230. PubMed ID: 33162827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.
    Vinatzer U; Dampier B; Streubel B; Pacher M; Seewald MJ; Stratowa C; Kaserer K; Schreiber M
    Clin Cancer Res; 2005 Dec; 11(23):8348-57. PubMed ID: 16322295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer.
    Noske A; Kaszubiak A; Weichert W; Sers C; Niesporek S; Koch I; Schaefer B; Sehouli J; Dietel M; Lage H; Denkert C
    Cancer Lett; 2007 Feb; 246(1-2):190-200. PubMed ID: 16584837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
    Ripple MO; Kalmadi S; Eastman A
    Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.